Kitov Pharma (PPBT): Net earnings per share growth forecast for next year
Israeli management at Purple Biotech (PPBT) maintains strict cost controls, which supports business stability. The projected 12-month forward EPS trajectory, where the latest figure stands at 82.90, is based on a virtual development model and the outsourcing of production in Europe and the US. Growth potential relies on the creation of antibodies for pancreatic cancer therapy with subsequent reimbursement through health insurance.
purple-biotech.com (PPBT) - metric breakdowns and financial figures
- share price and consensus valuation forecast:
- stock exchange capitalization data:
- company book value details:
- business debt structure and liquidity details:
- earnings and market ratios statistics:
PPBT - Company Net Income|Projected Future Earnings Purple Biotech|PPBT - Business Payback Period|Future Price to Earnings Purple Biotech|PPBT - Price to Earnings Adjusted for Growth Rate|Enterprise Value to EBITDA Ratio Purple Biotech|PPBT - Company profit before taxes, interest and amortization|Net earnings per share (EPS TTM) Purple Biotech|PPBT - Net earnings per one share for the last twelve months|Quarterly EPS earnings growth purple-biotech.com|PPBT - Net earnings per share growth this year|Earnings growth forecast for next year Purple Biotech
Summary company analysis:Purple Biotech Corp, PPBT
This indicator mathematically captures the market consensus for expected earnings per share growth, stripping the calculation model of traders' emotional fluctuations. By analyzing the trend of earnings per share growth forecasts, an investor assesses the monetization potential of the CM24 antibody and the effectiveness of the Purple Biotech (PPBT) patent perimeter in overcoming tumor resistance, while accounting for interest rate volatility risks.
Competitors of Purple Biotech
ONC (BeiGene Corp) - Earnings growth forecast for next year|Expected net earnings per share growth next year Halozyme Corp HALO|Net earnings per share growth forecast for next year Revolution Medicines (RVMD)|AAPG: Net earnings per share change forecast for next year|CG Oncology - Expected earnings per share growth for next year|Earnings growth forecast for next year UroGen Pharma Ltd URGN|BCAX - Net earnings per share growth forecast for next year|Expected earnings per share trend next year PSNL (Personalis Genomics)|Erasca, Inc. (ERAS) - Net earnings per share growth forecast for next year|Net earnings per share change forecast for next year DCTH (delcath.com)|Net earnings per share growth forecast for next year Y-mAbs Therapeutics, Inc.|Net earnings per share growth forecast for next year AURA|Earnings growth forecast for next year CADL|ARAY - Expected net earnings per share growth next year|SELLAS Life Sciences Group - Expected earnings per share growth for next year|Expected earnings per share trend next year ACTU|Citius Oncology - Earnings growth forecast for next year|HURA: Net earnings per share growth forecast for next year|TARA: Earnings growth forecast for next year|FATE - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Aadi Bioscience, Inc.|Expected net earnings per share growth next year TScan TCRX|Expected earnings per share growth for next year CSBR (Champions Oncology)|Projected earnings per share increase next year XBIT|Earnings growth forecast for next year CVM (CEL-SCI)|OS Therapies, Inc. (OSTX) - Expected net earnings per share growth next year|Radiopharm Theranostics Limited - Earnings growth forecast for next year|Artiva Biotherapeutics, Inc. (ARTV) - Expected earnings per share growth for next year|ANL: Earnings growth forecast for next year|Veru Inc - Expected earnings per share trend next year|Net earnings per share growth forecast for next year Tempest Tx|Xilio - Net earnings per share change forecast for next year|Net earnings per share growth forecast for next year Renovaro Inc. (RENB)|MURA: Net earnings per share change forecast for next year|Earnings growth forecast for next year KAPA (Kairos Pharma)|OnKure Therapeutics, Inc. - Net earnings per share growth forecast for next year|GDTC: Expected earnings per share growth for next year|Curis, Inc. - Projected earnings per share increase next year|APLM: Earnings growth forecast for next year|Expected earnings per share growth for next year tharimmune.com|ADVB (Advanced Biomed Inc.) - Earnings growth forecast for next year|Earnings growth forecast for next year Genprex Inc.|Net earnings per share growth forecast for next year Calidi Biotherapeutics (CLDI)|Sunshine Biopharma Inc. - Projected earnings per share growth rate for next year|Earnings growth forecast for next year XBIO (Xenetic Biosciences, Inc.)|SLRX - Expected earnings per share growth for next year|AON - Earnings growth forecast for next year|Expected net earnings per share growth next year BeiGene Ltd.|Checkpoint Therapeutics, Inc (CKPT) - Net earnings per share growth forecast for next year|elevationoncology.com - Expected earnings per share trend next year|Expected earnings per share growth for next year ICAD|IKNA: Expected earnings per share trend next year|Earnings growth forecast for next year NTBL|Expected earnings per share growth for next year viracta.com VIRX|MorphoSys Corp - Expected earnings per share growth for next year|Earnings growth forecast for next year NAYA Biosciences Corp NAYA|AAPGV - Net earnings per share growth forecast for next year
